Doha, Qatar: The View Hospital, in affiliation with Cedars-Sinai, offers Repetitive Transcranial Magnetic Stimulation (rTMS) therapy at its Psychiatry Department.

This advanced, non-invasive treatment provides new hope for individuals living with depression, chronic pain, and other conditions that have not responded to conventional therapies.

The rTMS is a safe, drug-free procedure that uses gentle magnetic pulses to stimulate specific areas of the brain responsible for mood regulation and pain control. Unlike traditional treatments, it requires no anesthesia, sedation, or hospitalisation, and is performed while the patient is fully awake and alert.

FDA approved for treatment of therapy resistant depression who have been not responded to medication or psychotherapy, while rTMS is most widely recognised for treating patients with depression who have not responded to medication, studies have also demonstrated its potential in managing anxiety disorders, OCD, PTSD, insomnia, and chronic pain conditions, offering a new horizon of care for diverse patient needs.

“rTMS remains a highly effective option to help improve your mood, bring a sense of calm, and may reignite your lost passion for life,” said Senior Consultant, Psychiatry and Clinical Psychology, The View Hospital, Dr. Maged Fahmy. “This treatment provides a safe and effective option for people who may have struggled for years without relief from medication or therapy, rTMS could be the opportunity that everyone has been waiting for, and it's worth giving it a chance.”

Since being introduced, rTMS therapy has delivered encouraging outcomes at The View Hospital, offering patients new hope in their recovery journey. Patients undergoing rTMS therapy typically attend daily sessions lasting around 20 minutes, five days a week, over a six-week period. In clinical practice, sustained improvement in mood and well-being is often observed, with minimal side effects limited to light headache.

“Our mission is to deliver advanced, patient-centred care, and the introduction of rTMS therapy reflects that commitment,” said Dr. Fatih Gul, Chief Executive Officer at The View Hospital.“We are proud to be among the few private hospitals in Qatar offering this cutting-edge treatment, giving our patients access to international standards of psychiatric care.” Depression affects more than 280 million people worldwide, and according to the World Health Organisation, around 5% from the adults experience clinically significant depressive symptoms.

Research from Harvard Health shows that around 60% of patients who did not respond to medication experienced meaningful improvement with rTMS, with about one-third achieving complete remission.

MENAFN25112025000063011010ID1110393115